Australia - English - Department of Health (Therapeutic Goods Administration)

boc limited - 43438 - oxygen cylinder regulator - the device is intended to provide a regulated flow of medical oxygen from stationary and portable cylinders to patients with therapeutic oxygen needs

Australia - English - Department of Health (Therapeutic Goods Administration)

rapp australia pty ltd - 43438 - oxygen cylinder regulator - a reduction valve designed to be attached via a pin indexed gastight connector to the valve stem of a cylinder filled with oxygen, to reduce the cylinders high variable gas pressure (e.g., 50 - 250 bar) to a lower, constant working pressure, typically 3 - 5 bar. it can be a single or a dual stage regulator, of a piston or diaphragm design. it has a safety relief valve to avoid excessive pressure, it has a manometer to display the available gas reserve of a gas cylinder, some models have an integrated flow control device to provide controlled gas flow generally in the ranges of 0.25 lpm to 25 lpm to allow administration of oxygen therapy or connection to a resuscitation bag (bvm). some models also have a low pressure outlet/s, typically 4 bar, to allow the connection of gas driven devices such as, for example, a suction unit and/or ventilator.

United States - English - NLM (National Library of Medicine)

remedyrepack inc. - abacavir sulfate (unii: j220t4j9q2) (abacavir - unii:wr2tip26vs) - abacavir 300 mg - abacavir tablets, in combination with other antiretroviral agents, are indicated for the treatment of human immunodeficiency virus (hiv-1) infection. abacavir tablets are contraindicated in patients: - who have the hla-b*5701 allele [see warnings and precautions ( 5.1)]. - with prior hypersensitivity reaction to abacavir [see warnings and precautions ( 5.1)].  - with moderate or severe hepatic impairment [see use in specific populations ( 8.6)]. pregnancy exposure registry there is a pregnancy exposure registry that monitors pregnancy outcomes in women exposed to abacavir during pregnancy. healthcare providers are encouraged to register patients by calling the antiretroviral pregnancy registry (apr) at 1-800-258-4263. risk summary available data from the apr show no difference in the overall risk of birth defects for abacavir compared with the background rate for birth defects of 2.7% in the metropolitan atlanta congenital defects program (macdp) reference population (see data). the apr uses the ma

United States - English - NLM (National Library of Medicine)

apotex corp - abacavir sulfate (unii: j220t4j9q2) (abacavir - unii:wr2tip26vs) - abacavir 300 mg - abacavir tablets, in combination with other antiretroviral agents, are indicated for the treatment of human immunodeficiency virus (hiv-1) infection. abacavir tablets are contraindicated in patients: - who have the hla-b*5701 allele [see warnings and precautions (5.1)]. - with prior hypersensitivity reaction to abacavir [see warnings and precautions (5.1)].  - with moderate or severe hepatic impairment [see use in specific populations (8.6)]. pregnancy exposure registry there is a pregnancy exposure registry that monitors pregnancy outcomes in women exposed to abacavir during pregnancy. healthcare providers are encouraged to register patients by calling the antiretroviral pregnancy registry (apr) at 1-800-258-4263. risk summary available data from the apr show no difference in the overall risk of birth defects for abacavir compared with the background rate for birth defects of 2.7% in the metropolitan atlanta congenital defects program (macdp) reference population (see data). the apr uses the macdp a

United States - English - NLM (National Library of Medicine)

energique, inc. - tilia x europaea flower (unii: nhv2k1oudh) (tilia x europaea flower - unii:nhv2k1oudh) - tilia x europaea flower 1 [hp_x] in 1 ml - may temporarily relieve sleeplessness with restlessness.** **claims based on traditional homeopathic practice, not accepted medical evidence. not fda evaluated. may temporarily relieve sleeplessness with restlessness.** **claims based on traditional homeopathic practice, not accepted medical evidence. not fda evaluated.

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

linde gas uk ltd - nitrous oxide; oxygen - inhalation gas - 500ml/1litre ; 500ml/1litre

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

linde gas uk ltd - oxygen; nitrous oxide - inhalation gas - 500ml/1litre ; 500ml/1litre

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

linde gas uk ltd - oxygen; nitrous oxide - inhalation gas - 500ml/1litre ; 500ml/1litre

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

linde gas uk ltd - oxygen; nitrous oxide - inhalation gas - 500ml/1litre ; 500ml/1litre

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

linde gas uk ltd - oxygen; carbon dioxide - inhalation gas - 950ml/1litre ; 50ml/1litre